COMP <GO>
ZJYL vs CDRE // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
JIN MEDICAL INTERNATIONAL LTD. (Class A) (NASDAQ) VS. Cadre Holdings Inc. (NYSE) • 15-METRIC TALLY: ZJYL 0
— CDRE 10
■ METRIC PARITY
LAST: $2.20 (-6.38%) • MKT CAP: $371.8M
options-implied-move
—
LAST: $31.51 (+3.79%) • MKT CAP: $1.30B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZJYL VS. CDRE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZJYL | CDRE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 29.20% | 42.50% | -13.30 | CDRE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 11.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 47.1x | 20.5x | +26.60 | CDRE | /valuation <GO> |
| Free Cash Flow Yield | -1.27% | 4.27% | -5.54 | CDRE | /fcf-yield <GO> |
| Operating Margin | 2.90% | 11.00% | -8.10 | CDRE | /operating-margins <GO> |
| Net Profit Margin | 5.80% | 7.20% | -1.40 | CDRE | /net-margins <GO> |
| Revenue Growth (YoY) | -12.00% | 7.50% | -19.50 | CDRE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.16% | -1.16 | CDRE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.32 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 9/9 | -5.00 | CDRE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.0 | 62.1 | -5.10 | CDRE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 28.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $371.8M | $1.30B | -$928.3M | CDRE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZJYL REV | CDRE REV | ZJYL GROSS % | CDRE GROSS % | ZJYL FCF | CDRE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.7M | $610.3M | 29.2% | 42.5% | -$3.7M | $56.8M |
| FY 2024 | $23.5M | $567.6M | 40.4% | 41.1% | -$1.4M | $26.1M |
| FY 2023 | $19.8M | $482.5M | — | — | $3.1M | $73.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZJYL // BETA —
CDRE // BETA —